Photodynamic therapy for choroidal neovascularization in pediatric patients

Retina

Volumn 25, Issue 5, 2005, Pages 590-596

  Giansanti, Fabrizio ^a   Virgili, Gianni ^a   Varano, Monica ^b   Tedeschi, Massimiliano ^b   Rapizzi, Emilio ^a   Giacomelli, Giovanni ^a   Menchini, Ugo ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

^b IRCCS FONDAZIONE BIETTI   (Italy)

Author keywords

Children; Choroidal neovascularization; Photodynamic therapy; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE;

ADOLESCENT; ARTICLE; CLINICAL ARTICLE; FEMALE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; MALE; PEDIATRICS; PHOTODYNAMIC THERAPY; SCHOOL CHILD; SIDE EFFECT; SUBRETINAL NEOVASCULARIZATION; TOXOPLASMOSIS; TREATMENT OUTCOME; VISUAL ACUITY;

ADOLESCENT; CHILD; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; FOLLOW-UP STUDIES; HUMANS; MALE; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; SAFETY; TREATMENT OUTCOME; VISUAL ACUITY;

EID: 23044506529     PISSN: 0275004X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006982-200507000-00009     Document Type: Article

References (9)

1. TAP Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: 2-year results of 2 randomized clinical trials-TAP report 2. Arch Ophthalmol 2001;119:198-207.
2. VIP Study Group. Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial-VIP report no. 3. Ophthalmology 2003;110:667-673.
3. Mimouni KM, Bressler SB, Bressler NM. Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in children. Am J Ophthalmol 2003;135:900-902.
4. Sickenberg M, Schmidt-Erfurth U, Miller JW, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocular histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000;117:327-336.
5. Roundtable 2000 and 2001 Participants, Treatment of Age-Related macular degeneration with Photodynamic therapy (TAP) Study Group Principal Investigators, and Verteporfin In Photodynamic therapy (VIP) Study Group Principal Investigators. Guidelines for using verteporfin (Visudyne) in photodynamic therapy to treat choroidal neovascularization due to age-related macular degeneration and other causes. Retina 2002;22:6-18.
6. Husain D, Miller JW, Michaud N, et al. Long term effect of photodynamic therapy (PDT) using liposomal benzoporphyrin derivative on experimental choroidal neovascularization (CNV) and normal retina and choroid. Invest Ophthalmol Vis Sci 1996;37:8223.
7. Reinke MH, Canakis C, Husain D, et al. Verteporfin photodynamic therapy retreatment of normal retina and choroid in the cynomolgus monkey. Ophthalmology 1999;106:1915-1923.
8. Hamovici R, Kramer M, Miller JW, et al. Localization of lipoprotein-delivered benzoporphyrin derivative in the rabbit eye. Curr Eye Res 1997;16:83-90.
9. Noske UM, Schmidt-Erfurth U, Meyer C, Diddens H. Lipid metabolism in retinal pigment epithelium. Possible significance of lipoprotein receptors. Ophthalmologe 1998;95:814-819.